[ Tips ] 一分鐘使用導覽
商品編號： TB0105 出版日期： 2005/10/27 作者姓名： Petitt, Barbara S. 商品類別： Finance 商品規格： 27p 再版日期： 地域： France 產業： Pharmaceuticals 個案年度： -
商品敘述：
It was late on Thursday, April 22, 2004, and Jean-Francois Dehecq, the Chief Executive Officer (CEO) of Sanofi-Synthe labo (Sanofi), France''s second largest pharmaceutical company, was sitting in his office thinking about what had happened over the last three months. On January 26, 2004, he had launched a hostile tender offer to acquire Aventis, France''s largest pharmaceutical company. The merger between Sanofi and Aventis would have created the world''s third largest pharmaceutical company, closing the gap with U.S.-based Pfizer and U.K.-based GlaxoSmith-Kline (GSK). Jean-Francois Dehecq had offered 48.6 billion, but his offer had been rejected by Aventis''s Supervisory Board. Since the end of January, Aventis had been fighting back, launching a poison pill and inviting Novartis, Switzerland''s largest pharmaceutical company, to act as a white knight.
涵蓋領域：
相關資料：
Case Teaching Note, (TB0106), 15p, by Barbara S. Petitt
哪些人也有訂購？